News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
189,492 Results
Type
Article (13285)
Company Profile (32)
Press Release (176175)
Multimedia
Podcasts (17)
Webinars (1)
Section
Business (63084)
Career Advice (620)
Deals (8773)
Drug Delivery (37)
Drug Development (36714)
Employer Resources (41)
FDA (4810)
Job Trends (4594)
News (109874)
Policy (8120)
Tag
2024 BioCapital Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Genetown Digital (2)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
Academia (889)
Accelerated approval (2)
Adcomms (12)
Allergies (38)
Alliances (12185)
ALS (49)
Alzheimer's disease (476)
Antibody-drug conjugate (ADC) (54)
Approvals (4815)
Artificial intelligence (75)
Autoimmune disease (13)
Automation (7)
Bankruptcy (68)
Best Places to Work (3978)
BIOSECURE Act (15)
Biosimilars (33)
Biotechnology (28)
Bladder cancer (40)
Brain cancer (15)
Breast cancer (141)
Cancer (1060)
Cardiovascular disease (80)
Career advice (525)
Career pathing (12)
CAR-T (69)
Cell therapy (172)
Cervical cancer (11)
Clinical research (31300)
Collaboration (232)
Compensation (73)
Complete response letters (9)
COVID-19 (1147)
CRISPR (23)
C-suite (37)
Cystic fibrosis (36)
Data (966)
Denatured (4)
Depression (19)
Diabetes (96)
Diagnostics (2343)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (38)
Drug pricing (36)
Drug shortages (5)
Duchenne muscular dystrophy (34)
Earnings (40440)
Editorial (11)
Employer branding (8)
Employer resources (36)
Events (21284)
Executive appointments (125)
FDA (5269)
Featured Employer (6)
Frontotemporal dementia (2)
Funding (191)
Gene editing (67)
Generative AI (9)
Gene therapy (135)
GLP-1 (300)
Government (1292)
Grass and pollen (2)
Guidances (23)
Healthcare (4911)
Huntington's disease (10)
IgA nephropathy (13)
Immunology and inflammation (47)
Indications (16)
Infectious disease (1205)
Inflammatory bowel disease (44)
Inflation Reduction Act (6)
Influenza (21)
Intellectual property (34)
Interviews (112)
IPO (4953)
IRA (20)
Job creations (795)
Job search strategy (422)
Kidney cancer (7)
Labor market (12)
Layoffs (197)
Leadership (3)
Legal (1006)
Liver cancer (43)
Lung cancer (178)
Lymphoma (76)
Machine learning (1)
Management (9)
Manufacturing (95)
MASH (30)
Medical device (2947)
Medtech (2949)
Mergers & acquisitions (3968)
Metabolic disorders (274)
Multiple sclerosis (47)
NASH (13)
Neurodegenerative disease (42)
Neuropsychiatric disorders (17)
Neuroscience (731)
NextGen: Class of 2025 (1411)
Non-profit (978)
Northern California (1000)
Now hiring (4)
Obesity (147)
Opinion (85)
Ovarian cancer (30)
Pain (29)
Pancreatic cancer (49)
Parkinson's disease (66)
Partnered (4)
Patents (57)
Patient recruitment (43)
Peanut (22)
People (8946)
Pharmaceutical (8)
Pharmacy benefit managers (4)
Phase I (8471)
Phase II (13781)
Phase III (12293)
Pipeline (659)
Policy (56)
Postmarket research (823)
Preclinical (2546)
Press Release (26)
Prostate cancer (53)
Psychedelics (14)
Radiopharmaceuticals (64)
Rare diseases (153)
Real estate (1157)
Recruiting (21)
Regulatory (6623)
Reports (16)
Research institute (868)
Resumes & cover letters (116)
Rett syndrome (1)
RNA editing (1)
RSV (25)
Schizophrenia (38)
Series A (38)
Series B (19)
Service/supplier (1)
Sickle cell disease (31)
Southern California (816)
Special edition (5)
Spinal muscular atrophy (72)
Sponsored (10)
Startups (888)
Stomach cancer (8)
Supply chain (16)
Tariffs (6)
The Weekly (12)
United States (7462)
Vaccines (298)
Venture capitalists (15)
Weight loss (105)
Women's health (5)
Worklife (6)
Date
Today (27)
Last 7 days (184)
Last 30 days (763)
Last 365 days (11374)
2025 (3182)
2024 (12106)
2023 (13637)
2022 (17596)
2021 (18009)
2020 (15960)
2019 (12393)
2018 (9224)
2017 (10435)
2016 (9207)
2015 (10662)
2014 (7337)
2013 (5635)
2012 (5966)
2011 (6195)
2010 (5598)
Location
Africa (220)
Alabama (20)
Alaska (2)
Arizona (52)
Arkansas (2)
Asia (12005)
Australia (1987)
California (2191)
Canada (593)
China (192)
Colorado (78)
Connecticut (90)
Delaware (58)
Europe (27013)
Florida (282)
Georgia (61)
Idaho (10)
Illinois (126)
India (7)
Indiana (109)
Iowa (4)
Japan (74)
Kansas (28)
Kentucky (5)
Louisiana (2)
Maine (27)
Maryland (239)
Massachusetts (1452)
Michigan (53)
Minnesota (94)
Missouri (26)
Montana (9)
Nebraska (7)
Nevada (17)
New Hampshire (18)
New Jersey (701)
New Mexico (13)
New York (569)
North Carolina (292)
North Dakota (6)
Northern California (1000)
Ohio (46)
Oregon (4)
Pennsylvania (396)
Puerto Rico (7)
Rhode Island (7)
South America (317)
South Carolina (2)
Southern California (816)
Tennessee (21)
Texas (277)
Utah (53)
Virginia (31)
Washington D.C. (13)
Washington State (186)
Wisconsin (12)
189,492 Results for "second genome".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug pricing
Novo’s Ozempic, Wegovy Targeted in Second Round of IRA Drug Price Negotiations
Drugmakers will have until the end of February to decide whether they want to participate in the second round of Medicare negotiations or not. CMS has until June 1 to send an initial offer for the adjusted prices.
January 17, 2025
·
3 min read
·
Tristan Manalac
Press Releases
BioSkryb Genomics and Ultima Genomics Launch Collaborative Grant Program to Advance Oncology Research
April 23, 2025
·
5 min read
Press Releases
Pfizer Declares Second-Quarter 2025 Dividend
April 23, 2025
·
1 min read
Press Releases
Ecotone Achieves Breakthrough in Human Genome Understanding with Novel AI Technology
AI-Powered Genomic Mapping Could Revolutionize Treatment of Rare Genetic Diseases
January 16, 2025
·
1 min read
Press Releases
CD Genomics Launches Innovative NGS-BSP to Enhance Genomic Understanding
March 27, 2025
·
1 min read
Press Releases
10x Genomics Reports Second Quarter 2024 Financial Results
August 9, 2024
·
9 min read
Press Releases
Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025
April 14, 2025
·
2 min read
Press Releases
Moss Genomics Announces Genomics Business Update, Integrating Blockchain for Genomic Security and Transparency
February 25, 2025
·
7 min read
Business
Singular Genomics Reports Recent Highlights and Second Quarter 2024 Financial Results
August 13, 2024
·
7 min read
BioCapital
GENZEVA and RYLTI perform second genomic research study which yields another significant discovery
Findings from a second joint study by Genzeva, a leading molecular genetic laboratory that performs whole genome and clinical exome sequencing for clinical diagnostics and research, and tech innovator RYLTI again illustrate the potential of their breakthrough process to accelerate discovery in genomic research.
November 15, 2023
·
3 min read
1 of 18,950
Next
